Rigel Pharmaceuticals, Inc. (RIGL)
NASDAQ·Healthcare·Biotechnology
$40.50
+2.14%
Mkt Cap $958.09M
Analyst Ratings
Buy
6
Hold
2
Sell
0
Price Target (6 analysts)
$67.00
Range $49.00 – $85.00
Implied Upside
+65.4%
Consensus $67.00 vs current $40.50
NASDAQ·Healthcare·Biotechnology
$40.50
+2.14%
Mkt Cap $958.09M
Buy
6
Hold
2
Sell
0
Price Target (6 analysts)
$67.00
Range $49.00 – $85.00
+65.4%
Consensus $67.00 vs current $40.50